Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Lorazepam in Alcohol Withdrawal
NCT00229125Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in alcohol withdrawal syndrome (AWS), sponsored by National Institute on Alcohol Abuse and Alcoholism. Started Jul 2001; status: completed.
02
Drugs
gabapentin
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT00229125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229125.